This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced the completion of the previously announced cash tender offer by its wholly-owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), for any and all of the Issuer’s approximately $934 million aggregate principal amount of 8⅞% Senior Notes due 2015 then outstanding (the “Notes”). The tender offer expired at 5:00 p.m., New York City time, on August 1, 2012 (the “Expiration Time”).
As previously announced, as of 5:00 p.m., New York City time, on July 17, 2012 (the “Consent Expiration”), $639,705,000 aggregate principal amount, or approximately 68.5 percent, of the outstanding Notes had been validly tendered and not withdrawn and the holders thereof consented to the proposed amendments to the indenture governing the Notes set forth in an Offer to Purchase and Consent Solicitation Statement (the “Offer to Purchase”) that was sent to holders of the Notes. The Issuer accepted for purchase all Notes that had been validly tendered and not withdrawn. Payment for Notes accepted for purchase at the Consent Expiration was made on July 18, 2012, and the proposed amendments referred to above became operative on July 18, 2012. No additional Notes were tendered after the Consent Expiration and prior to the Expiration Time.
The Issuer retained Credit Suisse Securities (USA) LLC to act as Dealer Manager and Solicitation Agent in connection with the tender offer and consent solicitation. Questions about the terms of the tender offer and consent solicitation may be directed to Credit Suisse Securities (USA) LLC at (800) 820-1653 (toll-free) or (212) 538-2147 (collect). Copies of the tender offer and consent solicitation documents and other related documents may be obtained from D.F. King & Co., Inc., the Tender and Information Agent for the tender offer, at (800) 290-6427 (toll-free).
The tender offer and consent solicitation were made solely by means of the Offer to Purchase and the related Consent and Letter of Transmittal. Under no circumstances shall this press release constitute an offer to purchase or the solicitation of an offer to sell the Notes or any other securities of the Issuer or any other person, nor shall there be any offer or sale of any Notes or other securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No recommendation is made as to whether holders of the Notes should tender their Notes.